Expression of catalytic proteasome subunits in the gut of patients with Crohn’s disease
Open Access
- 10 March 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Colorectal Disease
- Vol. 24 (10), 1133-1139
- https://doi.org/10.1007/s00384-009-0679-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Dextran Sulfate Sodium-Induced Colitis Is Associated with Enhanced Low Molecular Mass Polypeptide 2 (LMP2) Expression and Is Attenuated in LMP2 Knockout MiceDigestive Diseases and Sciences, 2006
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6JCI Insight, 2006
- Transforming growth factor-β induces development of the TH17 lineageNature, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- The proteasome and MHC class I antigen processingBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004
- Proteasome inhibition: a new anti-inflammatory strategyJournal of Molecular Medicine, 2003
- Missing Pieces in the NF-κB PuzzleCell, 2002
- Protein degradation and the generation of MHC class I-presented peptidesAdvances in Immunology, 2002
- The catalytic sites of 20S proteasomes and their role in subunit maturation: A mutational and crystallographic studyProceedings of the National Academy of Sciences, 1999
- A role for transcription factor NF- k B in intestinal inflammationInternational Journal of Colorectal Disease, 1999